Cosmetic Breast Surgery - For patients who want to have their assessment and surgery by an Experienced Specialist who focuses just on the Breast
This site is a comprehensive source of information about Cosmetic Breast Surgery. For outpatient consultaion or bookings advice please go straight to the Book a Consultation tab. This site has been personally designed and authored by Mr Philip Turton and delibertately avoids the typical commercial style, aiming to be as informative to his patients as possible, Mr Turton is leading Specialist Consultant Breast, Oncoplastic and Aesthetic Breast Surgeon. His Specialist Cosmetic Breast Surgery practice (this includes all clinical assessments, surgery and out-patients) is located at the state-of-the-art Leeds Nuffield Hospital or the Spire Hospital Leeds where he has built a nationwide reputation for over twelve years.
Mr Turton's philosophy is centred on providing patients with the best outocme and experience. As a UK trained and practicing consultant you will get independent advice, quality assurance, and the level and depth of experience necessary for safe and expert surgery. Mr Turton uses cutting edge techniques and individualises his paitent care.
His national reputation is reflected in the size of his practice. Patients travel from all over the UK and even from abroad reflecting the high demands on his focused area of expertise. The ease of transport access to the Nuffield Hospital Leeds makes this particularly attractive to patients where he holds a dedicated Saturday Cosmetic Breast Clinic. This is just a 5-minute walk from the Leeds train station, or 15-minute drive from Leeds Bradford airport. There is of course on-site parking for those who are driving. (For accurate SatNav directions please enter '2 Leighton Street, Leeds' (Leighton Street intersects with Great George Street).
Mr Turton has Full Registration on the GMC Specialist Register (GMC number 3613582) having qualified as a Doctor in 1992. He trained in the Specialty of General Surgery and then Specialised further in Breast and Reconstructive Breast Surgery gaining his FRCS prior to his Consultant Beast Surgeon appointment at the Leeds Teaching Hospitals Trust Breast Unit in 1994. In addition to his Breast, Oncoplastic and Aesthetic Breast Surgery clinic at the Leeds Nuffield and Spire Hospitals, he holds a substantive post as a Consultant Breast and Reconstructive Breast Surgeon at the Leeds Teaching Hospitals Trust, based at St James's Hospital Leeds. Click HERE for further information.
Mr Turton's Surgical Practice is based exclusively in the Specialty of Breast, Cosmetic Breast and Reconstructive Breast Surgery. Mr Turton is both an Oncoplastic Breast Surgeon (he uses breast plastic surgery skills combined with breast oncology surgery skills) and an Aesthetic Breast Surgeon (he has a dedicated and long established special interest and track record in Cosmetic Breast Surgery). His consultant level experience now comprises thousands of breast operations over the last 12 years. Mr Turton also provides cosmetic injections (non-permanent fillers with Juvederm Volbella for natural lips, Volift for naso-labial folds and Voluma for cheeks to give a more rejuvenated look. Teatment can be directed at one area or patients may opt for the 8-point lift depending on their requirements and budget. For patients who want to reduce dynamic facial wrinkles Botox is used to give the face a fresher look with treatments directed at one, two or three areas).
Mr Turton provides all aspects of cosmetic beast surgery but the commonest request is for breast augmentation. He provides a comprehensive cosmetic breast surgery service (especially proportionate breast enlargement, any revisional implant surgery, breast reductions and full breast uplifts and re-shaping. He only uses the highest quality breast implants that are available, chosing quality and safety above all aspects. Due to this, his preferred implant manufacturer is Allergan, with the choice from the Natrelle range. However, Mr Turton is not tied to any one manufacturer and where appropriate will consider other choices. Mr Turton's information sheet for his patients having augmentation is provided here and offers helpful details relating to issues of consent, pre and post operative issues. He covers even the rare association with BIA-ALCL (breast implant associated anaplastic large cell lymphoma). More information is also provided further down this page.
Mr Turton offers breast enhancement with both the latest most natural shaped round implants and anatomical (shaped / tear drop) implants. However, some patients prefer a larger or more rounded look and this can be accommodated if it is safe, within reasonable technical limits, and the patient characteristcs support their use. Please remember that large volume implants accelerate breast sag and tissue thinning and is best avoided. Helping patients make the correct implant selection is one of his specialist areas and why he is highly receommended by his former patients; utilising a one-hour consultation per patient he takes detailed dimensions (biodimensional planning), an essential service to any person having breast enlargement who cares about their outcome.
He also sees patients who require replacement implants or revisional surgery having had an operation elsewhere that hasn't gone well. He undertakes all aspects of revisional surgery related to the removal or revision of problem implants, capsular contraction, or even patients that still have PIP implants that have been placed at other clinics/other surgeons whether from the UK or overseas. He has helped many women with revional surgery. See section on PIP implants!
Mr Turton almost universally uses the FDA and MHRA approved breast implants. There are only a small number of manufacturers in this category. Use of other manufacturers will be considered in special cases when this is appropriate. Mr Turton is strongly of the opinion that implant safety is paramount, and he therfore recommends the highest quality breast implants from the top world renowned manufacturers with their known Quality Assurance and scientific track record. Mr Turton has a less than 2% reported implant rupture rate in the last twelve years. He has also never had to remove an implant from any of his patients due to infection after breast augmentation in the last twelve years. Within the categories of different implants available from the best manufacturers he uses the latest styles of natural shaped round high-cophesive implants and anatomical implants. These encompass a diverse range of specialist products. Mr Turton also uses careful measurement tecniques derived from his years of experience in both cosmetic breast surgery and reconstructive breast surgery. He also has experience with computer assisted planning to facilitate implant selection where round or anatomical implants are required in primary augmentation.
Mr Turton's expertise and careful attention to detail has huge advantages in patients who have lost breast shape after prior pregnancies or those who have never had much breast development before and are quite thin who require a particular type of implant. Please contact his secretary directly to book for breast augmentation so that additional clinic time is available- this service is preferred at his Saturday planning clinic at the Leeds Nuffield Hospital or at Spire Hospital Leeds - Lisa Harris, by email on email@example.com or by phone: 0113 3882193
The Allergan Breast Implants: The Allergan Natrelle style TSM soft-touch, TSF soft-touch, 410 soft-touch and more cohesive gels and the dual gel style 510 breast implants are very specialised round and tear drop shape Generation 5 high cohesive gel products. These implants go beyond the CE certification- they are also FDA approved. This advanced implant range includes the very popular moderate and full round profile Allergan Natrelle textured implants which produce some of the most natural and aesthetic beautifully results possible, when used by the right surgeon and in the right patient. Mr Turton finds he can produce a superior result with these products with the special techniques he uses and with appropriate selection; Mr Turton will talk you through the selection process and share his very extensive experience with breast implants to help you make the right choices.
The Allergan breast implant range is not only FDA approved, but also covered by the manufacturer's limited life-time warranty. Allergan will provide a free replacement implant if there is ever a rupture (althought the cost of the surgical replacement is not covered). As a comparison, the PIP implants were reported in the French vigilance study to have a rupture rate as high as 10% at one-year. By contrast, the FDA-approved Allergan implants had a rupture rate of just 10% at 10 years in the FDA study. Please read the warranty details- a PDF copy of their warranty is available here. A schematic that highlights the Allergan breast implant product and the special barrier layer in the Allergan implant shell is also shown here. Mr Turton has worked as a consultant for Allergan, presenting at National meeings, as shown here at a recent Allergan Medical Institute event on Surgical Aesthetics chairing and lecturing with internationale experts Bill Adams and Arthur Swift, promoting excellence in clinical practice.
The micropolyurethane foam coated implants: Two companies can be considered if an MPU-coated silicone implant is desired: Polytech and Silimed. The Silimed MPU-coated silicone implants are distributed in the UK by Eurosurgical but are currently suspended from use as micro-particles were found on the outside of the implants and the manufacturer is required to resolve the issue. Silimed is the third largest implant manufacturer in the world. Polytech MPU-coated silicone implants are available to consider in specific situations where it may have an advantage giving patients access to an implant with an extremely low capsulation rate. They are often considered when capsular contraction is a particular concern (ie in patients who have had capsular contraction of a previous augmentation), or to eliminate the risk of rotation where a tear-drop syle implant is being considered (this is recognised as a complication for tear-drop implants in general). Patients are given all the facts relating to these implants to weigh up the advantages and disadvantages before this type is selected. The predominant disadvantage is that a larger incision is required for placement and they are harder to position correctly. They stick exactly where they are placed and no natural settling occurs; this can be difficult as a paient on an operating table is lying flat with her arms resting to the sides, which alters the breast dynamics compared to when sat upright with the arms relaxed. A surgeon using these implants must recognise this difference and try to judge the effect to position the implants correctly.
Polyurethane breast implants were first used as long ago as 1969. It is also worth noting that polyurethane has been implanted safely in humans for decades for other uses such as pacemakers and blood vessel grafts. Like all silicone gel implants, the foam covered implants have been improved over the years and now contain the same cohesive gel as other implants. Whenever a new implant is introduced it must be rigorously assessed over a long period of time to ensure it is safe. Significant studies now confirm the safety of polyurethane implants:
You can read more about the long term studies with micropolyurethane implants here. The coating on these implants were subjected to extensive safety review to ensure there was no health concern. There is nothing to suggest that polyurethane foam, or its in vivo breakdown products, pose a threat to the health or safety of patients. The foam is thought to breakdown over time and the protection against capsulation may therefore diminish. But although no head-to-head studies have been done, the long term case series show lower rates of capsulation compared to other implants. The foam breakdown has also been studied to ensure that doesn't pose any health concern. It is estimated that any risk from the foam in causing cancer is 1 in a million for example! Daniel Fleming (Australian plastic surgeon) has one of the largest experiences with this product and summarises the studies here.
Polyurethane implants have measurable advantages over smooth and mechanically textured gel-filled prostheses and do not appear to be associated with an increased risk of complications or morbidity.” (Handel, N. Long–term safety and efficacy of polyurethane foam-covered breast implants. Aesthetic Surgery Journal Vol.26 2006). Guillermo Vasquez, a plastic surgeon from Buenos Aires in Argentina reported his experience using these implants in 407 patients over a ten year period. He concluded“…this implant reduces capsular contracture to under 1%”
The possible degradation of polyurethane foam has been extensively
researched, with particular interest to 2,4-toluenediamine (TDA). Hydrolyses-
and biodegradation- studies show, that a minimal amount of
TDA can be released without endangering the patient (realistic assumptions
indicate a daily dose of 0.01 mg/kg body weight. In 1995 the American health authority “Food and Drug Administration” announced that the cancer
risk due to MicroPolyurethane-foam-Surfaced implants is less than
one in one million, over the lifetime of the patient. This figure represents no
significant danger according to the standard risk analysis. In relation to the "normal" risk of breast cancer, that, according to the WHO-statistics is one
in nine, in women who don't have breast implants, the possible extra risk due to the use of a micropolyurethane coated implant is totally negligible. The summary of this is presented here.
Re-do Revisional Breast Augmentation Surgery: Mr Turton has extensive experience performing correctional breast implant surgery for patients who have had complications from implants placed elsewhere in the UK. Patients travel to his clinics for review and revisional surgery from all over the UK; details of the best way to access his expertise when travelling from more remote parts of the UK or abroad will be provided on contacting his secretary (see consultation section for details).
PIP Breast Implants: Mr Turton never used PIP implants. The recent International withdrawal of the PIP (Poly Implant Prostheses) breast implant (a French manufacturer whose implants were marketed in the UK in many clinics) led to a flurry of referrals for Mr Turton to revise over the last few years. Any patients who still have PIP implants should have a consultation and consider exchanging them for a different manufacturer if they have symptoms. Mr Turton featured on the ITV programme as a specialist showing corrective surgery on patients with PIP implants.
Mr Turton offers implant exchange at both the Leeds Nuffield Hospital and Spire Hospital Leeds. Simple (like for like) exchange is realtively straightforward in patients who have minimal problems requiring a simple exchange (assessed at consultation). Short cuts must never be taken in patients who need expert surgery. PIP implants had been of a concern as they contained non-medical grade silicone. The French regulator's study of PIP implants have shown they bleed more silicone (the implant leaks some silicone through what appears to be a physically intact implant and this silicone can migrate to regional nodes or beyond). They also have a higher rupture rate and the non medical grade silicone is also a tissue irritant causing potential inflammation when it does come out. Please contact Lisa Harris, on 01133882193 to arrange for this type of consulation (please email if prefered: firstname.lastname@example.org). Mr Turton can retain the removed implants in most cases so that they can be returned to the patient if required for medical reports. Otherwise he will photograph the implants and document the operative findings for any such report. See the section on PIP implants on the side menu for further detailed information and the latest news.
ALCL: There are some extremely rare disorders in Medicine. ALCL (Anaplastic Large Cell Lymphom) is an extremely rare type of cancer of the T lymphocytes (white blood cells). The first case reported in the breast was around 1997. ALCL is recognised to very rarely occur in women's breasts although its incidence is over 1000 less than the standard type of breast cancer. Being incredibly rare it is estimated that there will be just 200 cases for every 100 million women in the population who have breast implants per year; It's occurence in the breast in women without implants is even more uncommon and estimated at 3 cases for every 100 million per year. For this reason it is associated in some women with implants (albeit with great rarity) in the scar tissue around the breast implant (the capsule) with a higher frequency than if they didn't have an implant. This possibility of a very rare link with silicone implants was suggested by the FDA in 2011. It is difficult to accurtely estimate the risk given it is so rare with slightly different rates in different countries: For example, In France out of 340,000 women with implants there had been just 12 cases reported by October 2013. In the UK, as of 2015 there were just 8 cases reported. In the USA as of 2011 there were just 17 cases reported, where 4-million women have had implants. Given that the background rate of breast cancer in the general population of women without breast implants is 1 a in 8 lifetime risk, the excess occurence of ALCL in women with implants is vanishingly small by comparison; but it is there and so women should be given the information that we have. Whilst we recognise that most women understand that ALCL is so unlikley that it has even been compared to the same minute chance of being struck by a comet each year, to others it could cause excessive worry even though it is so rare. Updated information for clinicans is avavailable from the Association of Breast Surgery.
Mr Turton runs a comprehensive breast service and offers a broad array of expertise in his clinics, with breast diagnosis and breast imaging, in addition to breast surgery. Please scroll down the Consultation page for a review of these services.
Male Breast Problems, such as Gynaecomastia: Mr Turton also specialises in the assessment of male breast disorders and all aspects of surgery for gynaecomastia. Male breast tissue excess (gynaecomastia) and fatty male breast tissue (usually called lipomastia or pseudo-gynaecomastia) requires particular expertise to treat. Excision of firm tissue and liposuction of fatty tissue may be required. Mr Turton performs all aspects of gynaecomastia assessment and treatment and this has included young men who have had the problem since puberty, sports stars, professional rugby players, weight lifters and body builders, young and middle age men who have acquired the disorder physiologically, and other patients who developed the disorder as a side effect of medication. His surgical techniques use the best cosmetic approaches to minimise scars. Male patients can just email his secretary Lisa Harris asking for a consultation - many patients dont like to talk about the problem and can use the following terms to make the booking as they please: "pectoral reduction" or "chest wall lump" or "gynaecomastia" consultation. Lisa has worked for me for over 10 years and very much understands the anxieties that some patient have.
Other Specialist Breast Surgery: For a summary of the comprehensive Specialist Breast Services available CLICK HERE.
Mr Turton operates from the two most prestigious Private Hospitals in the North of England: the BUPA Hospital Leeds, (now has been renamed Spire Hospital Leeds) situated in Roundhay Leeds (LS81NT) and the Leeds Nuffield Hospital, which has on-site uderground free parking and is located in the centre of Leeds (LS13EB) - it is just a 5-min walk from the main railway station. Patients regularly travel to see Mr Turton from all over the UK, with the particular advantage that Leeds is such an excellent transport hub. The Leeds Nuffield really is so close to the Leeds railway station that a very high number of patients travel from London for their cosmetic surgery. Patients from further afield fly in! We have a good proportion of Spanish and Irish patients who make use of the close proximity we have to Leeds Bradford Airport. It is just a 15-minute drive from Leeds and Bradford Airport (LBS). Both hospitals have state of the art equipment, comprehensive services and seamless integration with the multidisciplinary teams, as well as highly motivated professional and experienced staff. Of particular importance is that the hospital rates are amongst the most competitive in the UK.
Contact details may be found under the Consultation section of this web site, but are summarised here:
Direct Line- 0113 3882193
This web site contains a large amount of information on aesthetic breast surgery, and details Mr Turton's views. The goal is to provide a detailed source of education on cosmetic breast surgery and to serve as a professional guide to patients and medical staff. Mr Turton wants to help patients understand more about Breast Surgery, the Specialist Breast Surgeon, and dedicated services offered in his practice as a Breast Specialist and Cosmetic Breast Surgeon. Further information on breast augmentation provided by the MHRA, can be downloaded here. The Department of Health booklet on advise to women considering breast augmentation, can be downloaded here.
This web site offers a personal opinion and should not be construed as advice to any particular patient or their condition. It may be regarded as a source of general information eg to supplement that provided from a consultation. If you would like to suggest additional content please contact Webmaster@CosmeticBreastSurgeon.co.uk